Media Newsroom of

GeneTex, Inc.

2456 Alton Pkwy
Irvine, CA 92606
GeneTex, Inc.

At the forefront of antibody manufacturing, GeneTex has solidified its position in the research community and the biotechnology industry. Our commitment is to provide our customers with dependable reagents and to drive life science research.

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex, a leading international research antibody manufacturer, continues to expand and diversify its nearly comprehensive portfolio of SARS-CoV-2/COVID-19 reagents. Recently, the company has focused on developing products to help overcome the viral variants that threaten to undermine the social distancing…

GeneTex SARS-CoV-2 Nucleocapsid and Spike Antibodies Independently Validated by HistoWiz for Immunohistochemistry

GeneTex SARS-CoV-2 Nucleocapsid and Spike Antibodies Independently Validated by HistoWiz for Immunohistochemistry

GeneTex, Inc., a leading research antibody manufacturer, has developed the most comprehensive and well-characterized catalog of SARS-CoV-2 reagents for researchers. In an effort to further optimize these antibodies, GeneTex has partnered with HistoWiz, Inc., which specializes in histopathological services. The…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login